Based on the VanEck Bionic Engineering UCITS ETF A Acc EUR stock forecast from 0 analysts, the average analyst target price for VanEck Bionic Engineering UCITS ETF A Acc EUR is not available over the next 12 months. VanEck Bionic Engineering UCITS ETF A Acc EUR’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of VanEck Bionic Engineering UCITS ETF A Acc EUR is Bearish, which is based on 1 positive signals and 3 negative signals. At the last closing, VanEck Bionic Engineering UCITS ETF A Acc EUR’s stock price was EUR 19.81. VanEck Bionic Engineering UCITS ETF A Acc EUR’s stock price has changed by -1.44% over the past week, +0.42% over the past month and +7.09% over the last year.
No recent analyst target price found for VanEck Bionic Engineering UCITS ETF A Acc EUR
No recent average analyst rating found for VanEck Bionic Engineering UCITS ETF A Acc EUR
Company Overview VanEck Bionic Engineering UCITS ETF A Acc EUR
Frequently Asked Questions About VanEck Bionic Engineering UCITS ETF A Acc EUR (CIB0:XETRA) Stock
Stock Target Advisor's fundamental analysis for VanEck Bionic Engineering UCITS ETF A Acc EUR's stock is Bearish.
Unfortunately we do not have enough data on CIB0:XETRA's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on CIB0:XETRA's stock to indicate what its average analyst target is.
Unfortunately we do not have enough data on CIB0:XETRA's stock to indicate if its overvalued.
The last closing price of CIB0:XETRA's stock was EUR 19.81.
The most recent market capitalization for CIB0:XETRA is EUR 5.05M.
Unfortunately we do not have enough analyst data on CIB0:XETRA's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains VanEck Bionic Engineering UCITS ETF A Acc EUR's stock.
Sorry, we do not have any data on the number of employees for VanEck Bionic Engineering UCITS ETF A Acc EUR.
Sorry we do not have any infomation available on VanEck Bionic Engineering UCITS ETF A Acc EUR's address.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Low volatility
The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.
What not to like
Below median dividend returns
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
Poor risk adjusted returns
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
Low market capitalization
This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.
Frequently Asked Questions About VanEck Bionic Engineering UCITS ETF A Acc EUR (CIB0:XETRA) Stock
Stock Target Advisor's fundamental analysis for VanEck Bionic Engineering UCITS ETF A Acc EUR's stock is Bearish.
Unfortunately we do not have enough data on CIB0:XETRA's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on CIB0:XETRA's stock to indicate what its average analyst target is.
Unfortunately we do not have enough data on CIB0:XETRA's stock to indicate if its overvalued.
The last closing price of CIB0:XETRA's stock was EUR 19.81.
The most recent market capitalization for CIB0:XETRA is EUR 5.05M.
Unfortunately we do not have enough analyst data on CIB0:XETRA's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains VanEck Bionic Engineering UCITS ETF A Acc EUR's stock.
Sorry, we do not have any data on the number of employees for VanEck Bionic Engineering UCITS ETF A Acc EUR.
Sorry we do not have any infomation available on VanEck Bionic Engineering UCITS ETF A Acc EUR's address.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for CIB0:XETRA !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
